Michael S. Weiss
Overview
Michael S. Weiss received an average of $4M in total compensation, including $42K in salary, at Fortress Biotech from 2014 to 2023. Michael Weiss also received an average of $16M at TG Therapeutics from 2011 to 2021 and an average of $4M at Keryx Biopharmaceuticals from 2006 to 2009.
- 2023
- 2022
- 2021
- 2020
- 2019
- 2018
- 2017
- 2016
- 2015
Fortress BiotechExecutive Vice Chairman, Strategic Development
Fortress BiotechExecutive Vice Chairman, Strategic Development
TG TherapeuticsChief Executive Officer and President
TG TherapeuticsChief Executive Officer and President
TG TherapeuticsChief Executive Officer and President
TG TherapeuticsChief Executive Officer and President
TG TherapeuticsChief Executive Officer and President
TG TherapeuticsChief Executive Officer and President
Fortress BiotechExecutive Vice Chairman, Strategic Development
TG TherapeuticsChief Executive Officer and President
Source: SEC filings on April 5, 2024, April 29, 2022, April 29, 2020, April 30, 2019, April 30, 2018, April 26, 2017, April 24, 2013, April 30, 2010, and April 29, 2008.
Related executives
We found 25 more executives who work or worked at Fortress Biotech, TG Therapeutics, andKeryx Biopharmaceuticals.
David Jin
Fortress Biotech
Chief Financial Officer
Lindsay Rosenwald
Fortress Biotech
Chief Executive Officer
Sean Power
TG Therapeutics
Chief Financial Officer
Gregory Madison
Keryx Biopharmaceuticals
Chief Executive Officer
Christine Carberry
Keryx Biopharmaceuticals
Chief Operating Officer
John Neylan
Keryx Biopharmaceuticals
Chief Medical Officer
Scott Holmes
Keryx Biopharmaceuticals
Chief Financial Officer
Brian Adams
Keryx Biopharmaceuticals